[1]胡大一,马长生.心脏病学实践2004,规范化治疗[M].北京:人民卫生出版社,2004:265,585.
[2]郑莜萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:7377.
[3]谢东霞,毛秉豫.芪参益气滴丸对冠心病二级预防的临床观察[J].中国中医药信息杂志,2008,15(8):81.
[4]褚海峰,许英萍.急性心肌梗死的二级预防[J].现代中西医结合杂志,2010,19(17):2157.
[5]许连香,夏季平,陈立.冠心病二级预防中阿司匹林服药依从性与自我效能的相关性[J].中国疗养医学,2010,19(9):855856.
[6]中华医学会心血管病学分会和中华心血管病杂志编辑委员会.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281284.
[7]任德旺,韩海俊,孙青萍,等.参蛭心脑通胶囊与小剂量阿司匹林预防心脑血栓疾病的对比分析[J].内科,2008,3(6):872873.
[8]任德旺,黄振国,孙青萍,等.冠脑圣胶囊治疗不稳定型心绞痛临床观察[J].中西医结合心脑血管病杂志,2005,3(6):556556.
[9]张艳玲,莫炜,王龙生,等.重组双功能水蛭素抗凝防栓作用的实验研究[J].中华手外科杂志,2006,22(2):106108.(收稿日期:20121229)
[1]王嘉麟 邢佳 朱晓晨 郭蓉娟等
史华伟刘旭杜雅薇齐锡友董致郅王玲玲孟宪慧.脑梗死恢复早期实证患者的二级预防模式
研究[J].环球中医药,2014,7(03):172.
WANG Jia lin,XING Jia,ZHU Xiao chen,et al.Research on the secondary prevention schemes in treating excesssyndrome cerebral infarction patients at early recovery stage[J].,2014,7(02):172.
[2]吴爱明,娄利霞,张冬梅,等.益气活血药对心肌梗死大鼠心脏蛋白激酶C表达的影响[J].环球中医药,2015,8(09):1077.[doi:10.3969/jissn.1674-1749.2015.09.011]
WU Ai ming,LOU Li xia,ZHANG Dong mei,et al.Effects of Yiqi Huoxue drugs on expression of protein kinase C in rats with myocardial infarction[J].,2015,8(02):1077.[doi:10.3969/jissn.1674-1749.2015.09.011]
[3]张文洁,徐雅.己酮可可碱对心肌梗死后抑郁大鼠的行为学
特征变化的作用研究[J].环球中医药,2015,8(05):531.[doi:10.3969/j.issn.16741749.2015.05.005]
ZHANG Wen jie,XU Ya..Effect of pentoxifyline on behavioral characteristics changes in depression rats after myocardial infarction[J].,2015,8(02):531.[doi:10.3969/j.issn.16741749.2015.05.005]
[4]关梓桐,张文洁,李悦,等.急性心肌梗死后抑郁大鼠前炎症细胞因子肿瘤坏死因子α和白细胞介素1β的变化规律[J].环球中医药,2015,8(12):1446.[doi:10.3969/j.issn.1674.1749.2015.12.006]
GUAN Zi-tong,ZHANG Wen-Jie,LI Yue,et al.Variation of pro-inflammatory cytokine TNF-α and IL-1β in rat model of depression after acute myocardial infarction[J].,2015,8(02):1446.[doi:10.3969/j.issn.1674.1749.2015.12.006]